Friday, August 19, 2011
Subscribe to:
Posts (Atom)
skip to main |
skip to sidebar
September 1, 2012 Centennial Park
Aug 20 2004- Aug 21 2008 Joseph is finally at peace. Thanks for all your prayers and support.
Joe P Rally Run
September 1, 2012 Centennial Park
About Us
- Allen and Gillian
- In November 2007 our 3 year old son was diagnosed with a brain tumor, a grade IV astrocytoma known as glioblastoma multiforme. Joseph had three surgeries, 6 weeks of radiation at St. Jude's in Memphis, and multiple chemo drugs before God took him home the day after his fourth birthday on Aug. 21, 2008.
2 Timothy 4:7-8
I have fought the good fight, I have finished the race, I have kept the faith. Now there is in store for me the crown of righteousness, which the Lord, the righteous Judge, will award to me on that day—and not only to me, but also to all who have longed for his appearing.
Contact
Thanks for reading our blog and praying for our family. If you would like to send us an email please write to: agpeabody@gmail.com.
Hymn
Friends
A Favorite
Other Warriors
Friends' Blogs
Spurgeon's Morning and Evening
map
About Pediatric GBM
--Glioblastoma multiforme is a high-grade, or malignant, glioma, a tumor of the glial (supportive) tissue of the brain. Glioblastoma multiforme and anaplastic astrocytoma, account for approximately 10 percent of pediatric central nervous system tumors.
--The incidence of glioblastoma multiforme per 100,000 population is 0.2 in the under 14 year age group
--The prognosis for glioblastoma multiformes remains poor. The best reported survival rates for radically removed tumors treated with adjuvant radiation therapy approaches 25 percent at 5 years. This is a minority of patients, however, and most fall into the incompletely removed category with 5-year survival rates of less than 5 percent.
--The incidence of glioblastoma multiforme per 100,000 population is 0.2 in the under 14 year age group
--The prognosis for glioblastoma multiformes remains poor. The best reported survival rates for radically removed tumors treated with adjuvant radiation therapy approaches 25 percent at 5 years. This is a minority of patients, however, and most fall into the incompletely removed category with 5-year survival rates of less than 5 percent.